Safety and Efficacy of Low Intensity Shockwave Therapy in Treating Diabetic Foot Ulcers
Low intensity shockwaves for treating diabetic foot ulcers (DFUs) have been in evaluation for the past 5 years. Many researchers showed the effectiveness of Low intensity shockwaves of in accelerating the healing rate of non-ischemic chronic DFUs. Wang et al. showed, the use of Low intensity shockwaves on DFUs, significantly improved topical blood flow perfusion rate, increased cell proliferation and cell activity and decreased cell apoptosis.
The present study deals with the effect of low intensity shockwaves on DFUs. Shockwave treatment will be done together with the standard conventional treatment for DFUs, compared to a control group who will receive the same conventional standard of care.
研究概览
地位
条件
研究类型
注册 (预期的)
阶段
- 阶段2
- 阶段1
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Chronic non-healing diabetic foot ulcers for more than 2 months.
- Age 18-80 years
- Ankle Brachial Index (ABI) ≥0.6
- Diabetic Foot Ulcer with the long diameter of ≤7cm and a short diameter of ≥1cm
- The target ulcer is up to Wagner's grade 3
- Albumin level ≥25g/L
- Hemoglobin level ≥90g/L
- Estimated Glomerular Filtration Rate (eGFR) ≥30ml/min/1.73m2
- The patient agrees to comply with study protocol requirements, including the shockwave procedure, self-care of the ulcer (dressings, orthotics etc.) and all follow-up visit requirements
Exclusion Criteria:
- Pregnancy or lactation
- ABI <0.6
- The long diameter of the target ulcer is >7cm and the short diameter is <1cm
- The target ulcer is of Wagner's grade 4 or above
- Severe Hypoalbuminemia <25g/L
- Severe anemia, Hemoglobin level <90g/L
- eGFR <30ml/min/1.73m2
- Patients suffering from acute Charcot foot
- Severe edema of the treated limb
- Patient with present malignancy or past malignancy in the treated area
- Systemic chemotherapy/ radiation treatment within the last 6 months
- Deep vein thrombosis within the last 6 months
Any other experimental treatment or participation in other studies
-
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
实验性的:Extracorporeal Shockwave Therapy and debridement
The treatment will be performed as an outpatient care procedure with no anesthesia.
Patients will undergo wound debridement and cleansing before each treatment.
The transducer device will be positioned against the lesion area and shockwaves will be delivered at a gradually increasing energy, with a maximum energy level of 0.09mJ/mm2
|
|
有源比较器:debridement and cleansing.
The standard treatment to the control group and the treatment group will be performed as an outpatient care procedure with no anesthesia.
Patients will undergo wound debridement and cleansing.
The physician will treat the patient in regard to his medical state: antibiotic medication if needed, dressing and off loading with Orthotic devices
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
---|---|
To assess initial closure rate of the wound 4 weeks after the last treatment session, as compared to the control group receiving conventional standard of care.
大体时间:four weeks
|
four weeks
|
合作者和调查者
研究记录日期
研究主要日期
学习开始
初级完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.